.
In-Depth Review
Sales Force Effectiveness (SFE)
Dendrite International, Inc.
1425 Route 206 South
Bedminster, NJ 07921
Telephone: 908-443-2000
Fax: 908-470-9900
Email: info@dendrite.com
Web:
www.dendrite.com
In 1986, a small start-up company introduced pharmaceutical manufacturers
to its Series 2 software. Among the earliest of SFA applications, Series 2
ran on a "mobile" computer the size of a desk typewriter, but it never
wavered from its mission — enhancing visibility and communication between
field sales and the home office as a way of improving the effectiveness of
both organizations. Today, that company is known throughout the life
sciences industry as Dendrite. And that first sales force automation product
occupies a small place in industry lore, having helped usher in a
revolutionary event, the onset of the Automation Era in pharmaceutical
sales.
For Dendrite, much has changed on the way to becoming one of the global
leaders in pharmaceutical sales services. With the advent of volume-level
prescriber data in the mid 1990s, manufacturers began saturating the market
with reps in an effort to gain a greater share of voice with prescribers.
This time, Dendrite led the way again by introducing home office tools that
facilitated organizational alignment and enabled better sample management.
Despite the growing complexities of synchronizing sales and marketing in
this new era, Dendrite's groundbreaking solutions helped simplify
communications and uncover critical gains in productivity.
The same spirit of innovation that put Dendrite on the map continues today.
Some of the industry-leading companies we've integrated into our portfolio
include names like Synavant, BuzzeoPDMA, Optas and Opus Health. Through
strong organic growth and these strategic acquisitions, Dendrite alone has
assembled the industry expertise and unsurpassed technologies to help life
sciences companies improve bottom-line performance across all facets of
their critical operations — sales, marketing, compliance and clinical
trials.
After 20 years, Dendrite is still working behind the scenes to help achieve
the productivity improvements that put life science companies ahead.
CEGEDIM S.A. COMPLETES ACQUISITION OF DENDRITE INTERNATIONAL
Paris, France, May 9, 2007 - CEGEDIM S.A. (Euronext: CGM) today announced
the completion of its acquisition of Dendrite International, Inc. (NASDAQ:
DRTE), in accordance with the terms of an Agreement and Plan of Merger
announced on March 2, 2007. Dendrite shareholders approved the acquisition
on May 4, 2007, and the companies have today met all regulatory approvals
required for closing.
The combined company will create a major player in diversified sales,
marketing and compliance solutions to the global life sciences and
pharmaceutical industry. With a unique suite of integrated, value-added
products, the new company can address the global needs of its customers,
especially by merging CEGEDIM’s European strength with Dendrite’s US and
Asia-
Pacific key position.
Under the terms of the Agreement and Plan of Merger, CEGEDIM will pay $16.00
per outstanding share in cash for each share of Dendrite International
common stock outstanding, that is a total purchase price of $751 million.
CEGEDIM has financed this acquisition by a combination of cash on hand and a
fully committed bank facility. As of May 9, 2007 Dendrite will be wholly
owned and will start contributing to Cegedim’s consolidated results. On a
pro forma full year basis, the combined entity is expected to have estimated
revenues of $1.1 billion.
“We are pleased to close this transaction and to accelerate the integration
of our two companies” says Jean-Claude Labrune, Founder, Chairman and Chief
Executive Officer of CEGEDIM. “Dendrite truly has a very talented team, and
together we will extend our geographical presence while continuing to invest
in the development of innovative technologies. Our combined organization has
enhanced product offerings and is focused on providing the highest level of
service to our customers around the globe.”
Dendrite’s shares will cease to trade on the NASDAQ at the close of business
May 9, 2007.
About CEGEDIM:
CEGEDIM develops exclusive databases and high value added software
solutions. Its expertise falls into two divisions. The “Healthcare and
strategic data” division comprises services specifically designed for
pharmaceutical companies, healthcare professionals and health insurance
providers. The “Technologies and services” division covers a variety of
sectors.
Established as the European leader in its historic core business, CEGEDIM
provides the world’s largest pharmaceutical companies with vital support for
successful CRM (Customer Relationship Management) and helps measure sales &
marketing effectiveness. CEGEDIM’s CRM tools, backed by the Group’s powerful
strategic databases, also provide its clients with a clearer picture of
their markets and targets, optimizing both strategies and return on
investment.
Founded in 1969, and the only European company operating globally in this
market, CEGEDIM employs around 5,000 people and generated turnover of €541
million in 2006 in 75 countries. To learn more, please see our website:
http://www.cegedim.com/.
Product: Sales Force Effectiveness (SFE)
Current Version:
Category: On-Premise Medium Enterprise CRM
Solution
Sub-Category: Vertical Solution -
Pharmaceutical/Life Science
Client Platform:
Server Platform:
Database Platform:
Dendrite pioneered Sales Force Automation for the life science industry.
The same spirit of innovation has driven revolutionary principles like
human-centered design to make applications more intuitive and streamlined.
We've also leveraged the latest technologies, such as smart phone, to adapt
our enterprise solutions to the needs of limited-size sales forces typical
of emerging life science and medical device companies. With Dendrite
supporting your sales organization, you'll go beyond automation to achieve
true Sales Force Effectiveness (SFE).
Mobile Intelligence™
Dendrite's enterprise SFE solution, Mobile Intelligence™ provides sales
forces with a robust set of customer relationship management capabilities
that promotes team selling, multi-channel customer management, information
sharing, field reporting, and analytics — all within a life science-tailored
mobile application that is easy to use. The best of Mobile Intelligence
delivered on a monthly subscription basis via your sales rep's mobile phone.
Dendrite MICRO™
Dendrite MICRO™ gives small, mid-size and emerging life science companies
and medical device manufacturers a quickly deployed and affordable way to
enjoy the benefits of our industry-leading SFE solutions.
ForceMobile™
Highly configurable, highly functional, easy-to-use, and optimized for a
lower total cost of CRM ownership, this PDA-based SFE solution is designed
specifically for organizations requiring ultra-portability, instant data
access, and pen-centric functionality.
Dendrite Analyzer
Dendrite Analyzer is the flexible, easy-to-use data viewing and analysis
tool that standardizes the decision support and reporting process for all
levels of a life science sales organization.
For pricing details, please contact the company directly.
One of the larger players in the pharmaceutical segment, Dendrite should
be on the short list for any pharmaceutical vendor.
We have no plans to review this product at this time.
Short List:
If you are considering this program, you should also look at these other
CRM solutions:
Need help searching this site? Try this!
